CMS RBCS · Treatments · Injections and Infusions (nononcologic)

Injection - Vasodilator codes

3 CPT®/HCPCS codes, ranked by est. all-Medicare services — scaled from national Medicare Part B fee-for-service volume. Open any code for the full market view — ranked physician groups, geography, and 12-year trend.

CY2024 · National scale is an all-Medicare estimate · est. — scaled estimate — assumes MA utilization mirrors FFS; not an observation; the observed fee-for-service figure is shown adjacent. Part B · national figures

HCPCS · Treatment J2785 Injection, regadenoson, 0.1 mg CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 4.49M services · est. ▲ 5.1% YoY · 558,510 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 2.22M observed fee-for-service services

See the national market for J2785 → ranked groups · states · 12-yr trend

HCPCS · Treatment J2760 Injection, phentolamine mesylate, up to 5 mg CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 952 services · est. · 340 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 475 observed fee-for-service services

See the national market for J2760 → ranked groups · states · 12-yr trend

HCPCS · Treatment J0360 Injection, hydralazine hcl, up to 20 mg CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 257 services · est. ▼ 5.0% YoY · 78 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 129 observed fee-for-service services

See the national market for J0360 → ranked groups · states · 12-yr trend